In this interview, Deepak Bhatt, MD, FACC, and Alison L. Bailey, MD FACC, discuss Top Takeaways from 2023 in Interventional Cardiology. Dr. Bhatt discusses trials including FIRE, MULTISTARS, and TRILUMINATE.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
ORBITA-2 was designed to test whether stents reduce angina more than a placebo procedure in patients with single or multivessel disease on little or no antianginal medication at 12 weeks of follow up.
In this interview, Christopher Rajkumar, MD, Rasha Al-Lamee, MD, and William E. Boden MD,...